The Sema4 Story
Unlocking Answers to Your Health
More than a decade ago, the decoding of the human genome ushered in a new scientific era. This discovery paved the way for new developments in genomic research and medicine—yet, our understanding of the complexities of disease remains limited.
Introducing Sema4™—an innovative health information company dedicated to empowering healthier living through data.
Originating from the Mount Sinai Health System in New York City, Sema4 is an interdisciplinary partnership of scientists, doctors, engineers, clinicians, and genetic counselors. With a strong foundation of more than 160 years of clinical experience, world-class academic research, and pioneering information science, we are uniquely positioned to drive innovation in health.
We believe that the synthesis of information science and machine learning with the power of biodata at scale will revolutionize our ability to diagnose, treat, and prevent disease. At the center of our pursuit is a strong commitment to engaging patients as partners and sharing our data, so that every patient’s journey helps complete the greater picture.
Our name is derived from semaphore—a device used for sending signals. In this spirit, our team will discern signal from noise across trillions of data points in pursuit of our mission to gain meaningful insights into human health.
“For Sema4, reproductive genetic test are the foundation of an even more grandiose undertaking – collecting a universe of biodata so big and so powerful that it will blot out the one-size-fits-all model of care that has for so long dictated how doctors treat their patients…”
“Asthma is an incredibly complex condition associated with genetics, environmental factors, activity levels, the immune system, and more,” said Sema4 CEO, Eric Schadt… “We believe the only way to fully understand asthma is by using sophisticated modeling tools to mine the rich, multi-dimensional data set we aim to generate in this study.”